Antisense Oligonucleotides in Dyslipidemia Management: A Review of Clinical Trials.
Saved in:
| Title: | Antisense Oligonucleotides in Dyslipidemia Management: A Review of Clinical Trials. |
|---|---|
| Authors: | Ogieuhi IJ; Siberian State Medical University, Tomsk, Russia. Jude.ogieuhi@gmail.com., Callender K; Queen Elizabeth Hospital, Martindales Road, Bridgetown, St. Michael, Barbados., Odukudu GO; Morehouse School of Medicine, Atlanta, USA., Obi ES; East Tennessee State University, Johnson City, USA., Muzofa K; Siberian State Medical University, Tomsk, Russia., Babalola AE; Faculty of Dentistry, CollegeofMedicine, University of Ibadan, Ibadan, Nigeria., Ugiomoh OM; Siberian State Medical University, Tomsk, Russia., Umenzeakor KH; Nnamdi Azikiwe University Teaching Hospital Nnewi, Anambra State, Nnewi, Nigeria., Akingbola A; Department of Public Health, University of Cambridge, Cambridge, England, UK., Ayoson CO; Olabisi Onabanjo University, Ago-Iwoye, Ogun State, Nigeria., Agbo EU; Siberian State Medical University, Tomsk, Russia., Odoeke MC; University of Toledo, Toledo, OH, USA. |
| Source: | High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension [High Blood Press Cardiovasc Prev] 2025 Jan; Vol. 32 (1), pp. 33-47. Date of Electronic Publication: 2024 Oct 30. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9421087 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1985 (Electronic) Linking ISSN: 11209879 NLM ISO Abbreviation: High Blood Press Cardiovasc Prev Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
